Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernia, Ventral | 9 | 2018 | 20 | 1.580 |
Why?
|
| Surgical Mesh | 11 | 2014 | 24 | 1.430 |
Why?
|
| Herniorrhaphy | 9 | 2018 | 33 | 1.350 |
Why?
|
| Postoperative Complications | 20 | 2018 | 810 | 1.170 |
Why?
|
| Hernia, Inguinal | 7 | 2016 | 18 | 1.100 |
Why?
|
| Obesity, Morbid | 2 | 2017 | 96 | 0.940 |
Why?
|
| Adenocarcinoma | 6 | 2016 | 132 | 0.900 |
Why?
|
| Laparoscopy | 13 | 2016 | 184 | 0.870 |
Why?
|
| Esophageal Neoplasms | 7 | 2002 | 50 | 0.800 |
Why?
|
| Stomach Neoplasms | 3 | 2016 | 31 | 0.650 |
Why?
|
| General Surgery | 4 | 2015 | 50 | 0.570 |
Why?
|
| Middle Aged | 42 | 2018 | 7873 | 0.570 |
Why?
|
| Aged | 31 | 2018 | 7412 | 0.530 |
Why?
|
| Male | 45 | 2020 | 12400 | 0.520 |
Why?
|
| Cholecystectomy, Laparoscopic | 7 | 2015 | 20 | 0.520 |
Why?
|
| Gastroplasty | 1 | 2016 | 27 | 0.490 |
Why?
|
| Humans | 60 | 2020 | 22823 | 0.470 |
Why?
|
| Treatment Outcome | 22 | 2018 | 2934 | 0.470 |
Why?
|
| Clinical Clerkship | 3 | 2013 | 26 | 0.470 |
Why?
|
| Gastric Bypass | 1 | 2016 | 67 | 0.460 |
Why?
|
| Carcinoma | 3 | 2016 | 63 | 0.450 |
Why?
|
| Adult | 30 | 2018 | 6896 | 0.450 |
Why?
|
| Female | 42 | 2018 | 12904 | 0.440 |
Why?
|
| Educational Measurement | 3 | 2015 | 53 | 0.410 |
Why?
|
| Retrospective Studies | 25 | 2018 | 2976 | 0.410 |
Why?
|
| Recurrence | 10 | 2017 | 268 | 0.410 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2003 | 23 | 0.400 |
Why?
|
| Quality Improvement | 4 | 2014 | 128 | 0.400 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 55 | 0.370 |
Why?
|
| Hepatectomy | 6 | 2015 | 61 | 0.370 |
Why?
|
| Liver Neoplasms | 5 | 2000 | 102 | 0.350 |
Why?
|
| Esophagectomy | 5 | 2002 | 23 | 0.350 |
Why?
|
| Colectomy | 3 | 2016 | 20 | 0.350 |
Why?
|
| Curriculum | 2 | 2003 | 125 | 0.350 |
Why?
|
| Polytetrafluoroethylene | 2 | 2003 | 5 | 0.340 |
Why?
|
| Pancreatic Neoplasms | 5 | 2013 | 88 | 0.310 |
Why?
|
| Aged, 80 and over | 13 | 2017 | 3717 | 0.310 |
Why?
|
| Risk Factors | 9 | 2018 | 1966 | 0.270 |
Why?
|
| Students, Medical | 2 | 2013 | 48 | 0.270 |
Why?
|
| Ambulatory Surgical Procedures | 3 | 2007 | 64 | 0.250 |
Why?
|
| Prospective Studies | 9 | 2014 | 1487 | 0.250 |
Why?
|
| Survival Rate | 9 | 2015 | 312 | 0.250 |
Why?
|
| Smoking | 2 | 2016 | 158 | 0.230 |
Why?
|
| Hernia, Hiatal | 2 | 2014 | 13 | 0.210 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 1412 | 0.210 |
Why?
|
| Polypropylenes | 1 | 2003 | 1 | 0.200 |
Why?
|
| Prognosis | 6 | 2017 | 714 | 0.200 |
Why?
|
| Gastrectomy | 3 | 2015 | 28 | 0.190 |
Why?
|
| Ultrasonography | 4 | 2020 | 203 | 0.190 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2013 | 10 | 0.190 |
Why?
|
| Cholangiography | 4 | 2015 | 7 | 0.190 |
Why?
|
| Colorectal Neoplasms | 4 | 1997 | 105 | 0.180 |
Why?
|
| Laparotomy | 3 | 2020 | 17 | 0.180 |
Why?
|
| United States | 9 | 2016 | 1762 | 0.180 |
Why?
|
| Hernia, Femoral | 1 | 2001 | 1 | 0.170 |
Why?
|
| Adolescent | 6 | 2007 | 1874 | 0.170 |
Why?
|
| Mesenteric Cyst | 1 | 2020 | 2 | 0.170 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2000 | 7 | 0.160 |
Why?
|
| Lymphokines | 1 | 2000 | 10 | 0.160 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 11 | 0.160 |
Why?
|
| Early Diagnosis | 1 | 2020 | 50 | 0.160 |
Why?
|
| Elective Surgical Procedures | 2 | 2017 | 32 | 0.160 |
Why?
|
| Neovascularization, Pathologic | 1 | 2000 | 34 | 0.160 |
Why?
|
| Peritoneum | 2 | 2003 | 15 | 0.160 |
Why?
|
| Suture Techniques | 3 | 2007 | 112 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1997 | 163 | 0.150 |
Why?
|
| Pneumonia | 2 | 2016 | 61 | 0.150 |
Why?
|
| Surgical Wound Infection | 3 | 2016 | 77 | 0.150 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2018 | 3 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2000 | 188 | 0.140 |
Why?
|
| Compartment Syndromes | 1 | 2018 | 7 | 0.140 |
Why?
|
| Cholelithiasis | 1 | 1998 | 6 | 0.140 |
Why?
|
| Conservative Treatment | 1 | 2018 | 15 | 0.140 |
Why?
|
| Cholecystectomy | 3 | 2013 | 10 | 0.140 |
Why?
|
| Gallstones | 1 | 1998 | 6 | 0.140 |
Why?
|
| Liver | 2 | 1997 | 136 | 0.140 |
Why?
|
| Survival Analysis | 6 | 2015 | 225 | 0.140 |
Why?
|
| Lipoma | 1 | 2017 | 4 | 0.140 |
Why?
|
| Myoepithelioma | 1 | 2017 | 4 | 0.130 |
Why?
|
| Internship and Residency | 3 | 2015 | 196 | 0.130 |
Why?
|
| Databases, Factual | 5 | 2016 | 307 | 0.130 |
Why?
|
| Analysis of Variance | 3 | 2003 | 228 | 0.130 |
Why?
|
| Trachea | 1 | 1997 | 38 | 0.130 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1996 | 2 | 0.130 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2017 | 52 | 0.130 |
Why?
|
| Prostheses and Implants | 1 | 1997 | 133 | 0.120 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 7 | 0.120 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.120 |
Why?
|
| Portal Vein | 1 | 1996 | 45 | 0.120 |
Why?
|
| Thrombosis | 1 | 1996 | 51 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2017 | 377 | 0.120 |
Why?
|
| Certification | 1 | 2015 | 24 | 0.120 |
Why?
|
| Radiation Tolerance | 1 | 1995 | 4 | 0.120 |
Why?
|
| Fundoplication | 2 | 2013 | 21 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2015 | 22 | 0.120 |
Why?
|
| Hospital Costs | 1 | 1996 | 57 | 0.120 |
Why?
|
| Organs at Risk | 1 | 2015 | 7 | 0.120 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 7 | 0.120 |
Why?
|
| Radiation Oncology | 1 | 2015 | 14 | 0.120 |
Why?
|
| Liver Regeneration | 1 | 1995 | 24 | 0.110 |
Why?
|
| Clinical Competence | 3 | 2013 | 189 | 0.110 |
Why?
|
| Neoplasm Staging | 5 | 2015 | 350 | 0.110 |
Why?
|
| Logistic Models | 4 | 2016 | 350 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 78 | 0.110 |
Why?
|
| Gallbladder Neoplasms | 1 | 2015 | 6 | 0.110 |
Why?
|
| Esophagus | 2 | 2012 | 53 | 0.110 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 47 | 0.110 |
Why?
|
| Appendectomy | 1 | 2014 | 13 | 0.110 |
Why?
|
| Safety | 2 | 2007 | 34 | 0.110 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 16 | 0.110 |
Why?
|
| Appendicitis | 1 | 2014 | 15 | 0.110 |
Why?
|
| Lymphoma | 1 | 2014 | 35 | 0.110 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 34 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 97 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 795 | 0.110 |
Why?
|
| Pain, Postoperative | 3 | 2013 | 271 | 0.110 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 281 | 0.110 |
Why?
|
| Biliary Dyskinesia | 1 | 2013 | 3 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2014 | 30 | 0.100 |
Why?
|
| Cholestasis | 1 | 1993 | 7 | 0.100 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 3 | 0.100 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 25 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 235 | 0.100 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 3 | 0.100 |
Why?
|
| Length of Stay | 5 | 2014 | 298 | 0.100 |
Why?
|
| Duodenal Neoplasms | 1 | 2013 | 4 | 0.100 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 32 | 0.100 |
Why?
|
| Sepsis | 1 | 2014 | 75 | 0.100 |
Why?
|
| Operative Time | 4 | 2014 | 82 | 0.100 |
Why?
|
| Stents | 1 | 1993 | 75 | 0.100 |
Why?
|
| Abdominal Wall | 1 | 2013 | 6 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 40 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 255 | 0.100 |
Why?
|
| Sarcoma | 1 | 2015 | 140 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 67 | 0.100 |
Why?
|
| Kidney | 1 | 2013 | 141 | 0.100 |
Why?
|
| Prosthesis Implantation | 2 | 2013 | 25 | 0.090 |
Why?
|
| Time Factors | 4 | 2014 | 1258 | 0.090 |
Why?
|
| Esophageal Achalasia | 1 | 2012 | 17 | 0.090 |
Why?
|
| Morbidity | 3 | 2014 | 50 | 0.080 |
Why?
|
| Lymph Node Excision | 2 | 2015 | 26 | 0.080 |
Why?
|
| Reoperation | 5 | 2016 | 744 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2013 | 102 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 309 | 0.070 |
Why?
|
| Chicago | 2 | 2001 | 811 | 0.070 |
Why?
|
| Hernia, Abdominal | 1 | 2007 | 1 | 0.070 |
Why?
|
| Polyurethanes | 1 | 2007 | 5 | 0.070 |
Why?
|
| Omentum | 1 | 2007 | 7 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 103 | 0.070 |
Why?
|
| Child | 3 | 2001 | 1153 | 0.060 |
Why?
|
| Age Factors | 2 | 2016 | 633 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 572 | 0.060 |
Why?
|
| Sutures | 2 | 2003 | 33 | 0.060 |
Why?
|
| Algorithms | 2 | 2015 | 295 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 439 | 0.060 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 27 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1047 | 0.060 |
Why?
|
| Comorbidity | 2 | 2016 | 426 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 292 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 34 | 0.050 |
Why?
|
| Disease-Free Survival | 2 | 2000 | 161 | 0.050 |
Why?
|
| Probability | 1 | 2002 | 70 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2002 | 74 | 0.050 |
Why?
|
| Workload | 1 | 2001 | 26 | 0.040 |
Why?
|
| Models, Educational | 1 | 2001 | 22 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2017 | 546 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 1019 | 0.040 |
Why?
|
| Intraoperative Care | 2 | 1998 | 40 | 0.040 |
Why?
|
| Bile | 1 | 2020 | 5 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 14 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2000 | 11 | 0.040 |
Why?
|
| Barrett Esophagus | 1 | 2000 | 16 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2000 | 66 | 0.040 |
Why?
|
| Infant | 1 | 2001 | 478 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2000 | 85 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 563 | 0.040 |
Why?
|
| Endosonography | 1 | 1999 | 9 | 0.040 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 1999 | 4 | 0.040 |
Why?
|
| Patient Selection | 1 | 2000 | 166 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2000 | 198 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 6 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 1998 | 21 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2020 | 534 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 1997 | 294 | 0.030 |
Why?
|
| Bronchial Neoplasms | 1 | 1997 | 5 | 0.030 |
Why?
|
| Pilot Projects | 2 | 1997 | 370 | 0.030 |
Why?
|
| Groin | 1 | 2017 | 3 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2017 | 11 | 0.030 |
Why?
|
| Thigh | 1 | 2017 | 26 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 48 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 1997 | 86 | 0.030 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 30 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 438 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 101 | 0.030 |
Why?
|
| Cryosurgery | 1 | 1997 | 16 | 0.030 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 5 | 0.030 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2016 | 6 | 0.030 |
Why?
|
| Intestinal Polyps | 1 | 1996 | 1 | 0.030 |
Why?
|
| Mesenteric Veins | 1 | 1996 | 1 | 0.030 |
Why?
|
| Sigmoid Neoplasms | 1 | 1996 | 1 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 1996 | 9 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2016 | 16 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 323 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 42 | 0.030 |
Why?
|
| Cost Savings | 1 | 1996 | 29 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 103 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 1 | 0.030 |
Why?
|
| Bilirubin | 1 | 1995 | 10 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 107 | 0.030 |
Why?
|
| Intestines | 1 | 2016 | 77 | 0.030 |
Why?
|
| Cardia | 1 | 1995 | 3 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 1995 | 13 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1995 | 15 | 0.030 |
Why?
|
| Hypertension | 1 | 2016 | 163 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 103 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 1995 | 100 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 82 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 384 | 0.030 |
Why?
|
| Radiography | 1 | 1996 | 523 | 0.030 |
Why?
|
| Consensus | 1 | 2015 | 81 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 64 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 314 | 0.030 |
Why?
|
| Surgical Stapling | 1 | 1994 | 4 | 0.030 |
Why?
|
| Jejunum | 1 | 1994 | 10 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1994 | 22 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 133 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 1999 | 354 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 129 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 221 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 107 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2014 | 58 | 0.030 |
Why?
|
| Digestive System Neoplasms | 1 | 1993 | 5 | 0.030 |
Why?
|
| Rats | 1 | 1995 | 623 | 0.030 |
Why?
|
| Seroma | 1 | 2013 | 3 | 0.030 |
Why?
|
| Ileus | 1 | 2013 | 3 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 7 | 0.030 |
Why?
|
| Device Removal | 1 | 2013 | 68 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 517 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 1999 | 429 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 481 | 0.020 |
Why?
|
| Intraoperative Period | 3 | 1997 | 22 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1412 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 559 | 0.020 |
Why?
|
| Animals | 1 | 1995 | 3255 | 0.020 |
Why?
|
| Ischemia | 1 | 2007 | 22 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2007 | 24 | 0.020 |
Why?
|
| Blood Loss, Surgical | 2 | 1999 | 53 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2007 | 388 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2002 | 20 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 28 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 364 | 0.010 |
Why?
|
| Cystadenoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Cystadenocarcinoma | 1 | 1999 | 2 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1999 | 8 | 0.010 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1999 | 19 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1997 | 45 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1997 | 92 | 0.010 |
Why?
|
| Cisplatin | 1 | 1997 | 60 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1997 | 210 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1997 | 240 | 0.010 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 1994 | 7 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1994 | 13 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1997 | 858 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1993 | 4 | 0.010 |
Why?
|
| Puerto Rico | 1 | 1993 | 12 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 80 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1993 | 56 | 0.010 |
Why?
|